DRW Securities’s Novavax NVAX Stock Holding History

DRW Securities’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,200	Closed	-$2.03M	–	338
2021 Q1	$2.03M	Buy	+11,200	New	+$2.23M	0.08%	52

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

DRW Securities's NVAX Position: Q2 2026 in Review

DRW Securities increased its Novavax (NVAX) stake by 8.9% in Q2 2026, buying an estimated $18.7K and bringing the position to 25,697 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #707.

DRW Securities first reported a position in NVAX in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.01M in Q1 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

DRW Securities held 25,697 shares of Novavax worth $242K as of Q2 2026.
DRW Securities bought 2,090 Novavax shares in Q2 2026, an estimated $18.7K.
Novavax made up 0.01% of DRW Securities's portfolio in Q2 2026, its #707 holding.
DRW Securities first reported a position in Novavax in Q1 2021 and has held it in 5 quarters since.
DRW Securities's Novavax position peaked at $1.01M in Q1 2021.
268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.